Therefore, our present study delineates the effect of metformin on the activation of lung fibroblasts and the relationship between AMPK and BMP9 signal during this process, strongly supporting the notion that metformin might serve as a preventive and therapeutic agent for lung fibrosis. The gene discussed is GDF2; the disease is pulmonary fibrosis.